Caris Precision Oncology Alliance™,
The Precision Oncology Alliance consists of leading cancer centers that demonstrate a commitment to precision medicine and work collaboratively toward a common goal: to advance tumor profiling and establish standards of care for molecular testing in oncology. The POA was established to promote the study and appropriate use of molecular testing in the diagnosis and treatment of cancer.
New discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. The Caris Precision Oncology Alliance™ is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine. POA members have contributed to over 250 abstract, posters, and presentations at leading industry events over the last several years. Caris supports POA publication development through the Letter of Intent (LOI) process.